Leidos, University of Pittsburgh spend $10M for AI disease detection
The partnership will focus on building AI tools that accelerate heart disease and cancer detection with the aim of reducing diagnostic turnaround times.
The partnership will focus on building AI tools that accelerate heart disease and cancer detection with the aim of reducing diagnostic turnaround times.
Like DNA hard drives, the approach could lock the world’s data down for the long haul—if researchers can make it practical.
Maharashtra University of Health Sciences will explore the application of Nihilent’s Navarasa AI in mental health care.
The nervous and type 2 immune systems regulate each other via cytokines and neurotransmitters, suggesting previously unidentified therapeutic avenues.
Gradient Denervation Technologies announced today that it received FDA breakthrough device designation for its denervation system.
Genetic therapy is effective but can cost millions of dollars. Boro Dropulić, executive director of Caring Cross, says technology innovations and partnerships with hospitals and…
Dr. Justin Norden, CEO of a generative AI infrastructure company, warns hospitals and health systems to identify ROI, safety issues, risk, governance and long-term value…
At Fierce Healthcare, we keep track of all the venture capital being funneled into the health tech and digital health industries. | Persivia, an AI-driven digital…
Michael Kratsios says DEI has led to a loss of public trust in universities
Nature Biotechnology – Retargeted retrotransposons insert multi-kilobase cargo at new sites
Maharashtra University of Health Sciences will explore the application of Nihilent’s Navarasa AI in mental health care.